These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 8884658

  • 1. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T, Eriksson M, Sjöberg S, Nordin C.
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [Abstract] [Full Text] [Related]

  • 3. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K.
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [Abstract] [Full Text] [Related]

  • 4. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM, Coleman E, Simpson ST, Satjawatcharaphong C.
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [Abstract] [Full Text] [Related]

  • 5. Monoamine compounds in cerebrospinal fluid of healthy subjects punctured without preceding strict bed rest: a pilot study.
    Eklundh T, Gunnarsson T, Nordin C.
    Neuropsychobiology; 2001 Jan; 43(1):5-10. PubMed ID: 11150891
    [Abstract] [Full Text] [Related]

  • 6. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 Jan; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure.
    Eklundh T, Gunnarsson T, Ornhagen H, Nordin C.
    Aviat Space Environ Med; 2000 Nov; 71(11):1131-6. PubMed ID: 11086668
    [Abstract] [Full Text] [Related]

  • 8. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
    Takahashi S, Abe T.
    No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
    Kay AD, Schapiro MB, Riker AK, Haxby JV, Rapoport SI, Cutler NR.
    Ann Neurol; 1987 Apr; 21(4):408-11. PubMed ID: 2437853
    [Abstract] [Full Text] [Related]

  • 10. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
    Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG.
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):700-4. PubMed ID: 21295953
    [Abstract] [Full Text] [Related]

  • 11. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
    Mignot E, Laude D, Elghozi JL.
    J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
    [Abstract] [Full Text] [Related]

  • 12. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R, Ekstedt J, Anggård E.
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [Abstract] [Full Text] [Related]

  • 13. CSF monoamine patterns in pathological gamblers and healthy controls.
    Nordin C, Sjödin I.
    J Psychiatr Res; 2006 Aug; 40(5):454-9. PubMed ID: 16081105
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 15. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 16. Characterization of cerebrospinal fluid monoamine metabolites in peripubertal chimpanzees (Pan troglodytes).
    Fontenot MB, Musso MW, Watson SL, Anderson GM.
    J Med Primatol; 2010 Feb; 39(1):24-31. PubMed ID: 19843204
    [Abstract] [Full Text] [Related]

  • 17. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers.
    Nordin C, Eklundh T, Fernström V, Swedin A, Zachau AC.
    J Psychiatr Res; 1995 Feb; 29(2):133-40. PubMed ID: 7545235
    [Abstract] [Full Text] [Related]

  • 18. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).
    Sourkes TL, Young SN, Garelis E, Lal S.
    Acta Vitaminol Enzymol; 1975 Feb; 29(1-6):97-9. PubMed ID: 1244132
    [Abstract] [Full Text] [Related]

  • 19. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G.
    Prog Biochem Pharmacol; 1980 Feb; 16():133-40. PubMed ID: 6160594
    [Abstract] [Full Text] [Related]

  • 20. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
    Blennow K, Wallin A, Gottfries CG, Månsson JE, Svennerholm L.
    J Neural Transm Park Dis Dement Sect; 1993 Feb; 5(1):5-15. PubMed ID: 7679905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.